Prof. Andrew Tutt, Consultant Clinical Oncologist
Prof. Andrew Tutt
Consultant Clinical Oncologist
Prof. Tutt is a recommended Consultant Clinical Oncologist
Areas of expertise
- Clinical oncology
- Breast cancer
- Biological therapy
- Chemotherapy
- Radiotherapy
Recommendations for Prof. Tutt
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
byMr Nicolas Beechey-Newman, Breast Surgeon
❝An internationally-known oncologist, dealing particularly with triple negative breast cancer.❞
byMr Nicolas Beechey-Newman, Breast Surgeon
❝An internationally-known oncologist, dealing particularly with triple negative breast cancer.❞
Make an appointment
Address
-
London Bridge Hospital
27 Tooley Street, London, SE1 2PR
-
Private Care at Guy's at London Bridge Hospital
Guy's Cancer Centre, Great Maze Pond,, London, SE1 9RT
-
London Radiotherapy Centre
Borough Wing, Lower Ground Floor Guy's Hospital, London, SE1 9RT
-
Telephone or video consultation
Virtual
About Prof. Andrew Tutt
GMC number: 3453450
Year qualified: 1990
Place of primary qualification: University of Bristol
Areas of expertise
- Breast Cancer
- Chemotherapy
- Radiotherapy
Professional memberships
Articles by Prof. Andrew Tutt
Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node-positive breast cancers: prognostic value of histological immune and stromal features
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
Homologous recombination dna repair deficiency and parp inhibition activity in primary triple negative breast cancer
Roteomics of replicant perfusate detects changes in the metastatic lymph node microenvironment
Author correction: landscape of somatic mutations in 560 breast cancer whole-genome sequences
Integrin-mediated macrophage adhesion promotes lymphovascular dissemination in breast cancer
Pitfalls in assessing stromal tumor infiltrating lymphocytes (stils) in breast cancer
Controversial issues in the neoadjuvant treatment of triple-negative breast cancer
Genomic evolution of breast cancer metastasis and relapse
